Hyderabad: A Hyderabad-based biotech start-up, Utopia Therapeutics, has secured a United States patent for its pioneering immunotherapy-based obesity vaccine, marking a significant milestone ...

ANK-203 is a first-in-class anchored immunotherapy designed to unlock the full therapeutic potential of monoclonal antibody CD137 through localized delivery and retentionIn preclinical studies, ...

Mayo Clinic researchers and collaborators have identified a previously unrecognized way lung tumors weaken the immune system, ...

Draft guidance from NICE recommends durvalumab before and after surgery for muscle-invasive bladder cancer following phase 3 trial survival data.

ImmunityBio commands a premium valuation on the promise of Anktiva, a chemo-free immunotherapy platform showing early ...

Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally ...

Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do ...

The BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine has gone in this eighteenth edition to Carl June ...

Over the past years, I have closely followed the evolution of the global oncology industry. What I have observed is steady, structural growth supported by science, policy support, and increasing ...

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

Obesity and related metabolic disorders such as fatty liver disease and high triglycerides are rising globally, with limited long-term treatment options ...

Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.